miRNA Sequencing And Assay Market Report 2021: Increase in Research Studies that Focus on the Sequence Analysis of miRNAs (microRNA) Due to COVID-19 - Forecast to 2028
30 juil. 2021 07h13 HE
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report by Product & Service, by Technology, by Workflow, by Application...
2021 Global Exosome Market Size, Forecast, Trials and Trends, Featuring Profiles of 107 Competitors Including Abbexa, Ltd., Abnova, Aruna Bio and Tavec Pharma
22 avr. 2021 06h13 HE
|
Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2021" report has been added to ResearchAndMarkets.com's offering. ...
Global MiRNA Sequencing and Assay Market Forecast 2021-2027: MiRNA Sequencing and Assay Market for Library Preparation Products to Witness Rapid Growth
13 avr. 2021 04h48 HE
|
Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "MiRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product, Technology, and End User by Geography" report has...
MicroRNA Market Value Projected To Reach US$ 618.6 Million By 2027: Acumen Research And Consulting
06 avr. 2021 12h10 HE
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “MicroRNA Market– Global Industry Analysis, Market Size, Opportunities and Forecast,...
MicroRNA Market Worth Size USD 613.2 Million at 13.4% CAGR by 2027 Backed by Increasing Number of Clinical Trials in North America: Fortune Business Insights™
25 janv. 2021 06h55 HE
|
Fortune Business Insights
Pune, India, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The global microRNA market size is expected to showcase exponential growth by reaching USD 613.2 million by 2027 while exhibiting a CAGR of 13.4%...
World RNAi Market 2020-2025: Oncology is Expected to Hold Significant Market Share in the Therapeutics Type Area
31 août 2020 05h44 HE
|
Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "RNA-interference (RNAi) Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The...
Interpace Biosciences Announces Acceptance of first paper Demonstrating Clinical Performance of ThyGeNEXT with ThyraMIR
02 mars 2020 06h55 HE
|
Interpace Biosciences, Inc.
Parsippany, NJ, March 02, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG) today announced acceptance of the first manuscript reporting the clinical performance of the company’s...
DiamiR to Present at the GTCbio Biomarker Summit 2017
20 mars 2017 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 20, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Kira...
DiamiR Awarded $2.75M Grant for Development of CogniMIR(TM) for Early Detection of Alzheimer's Disease
15 mars 2017 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 15, 2017) - DiamiR, LLC, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the National Institute...
DiamiR Announces Formation of Advisory Board
07 janv. 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - January 07, 2016) - DiamiR Biosciences, a developer of innovative minimally invasive diagnostic tests for early detection and monitoring of neurodegenerative...